TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
RPH Pharmaceuticals AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
333,688
|
218,318
|
175,352 |
Financial expenses |
32,496
|
16,935
|
20,749 |
Earnings before taxes |
45,004
|
35,184
|
48,872 |
EBITDA |
110,727
|
70,491
|
52,367 |
Total assets |
324,300
|
284,417
|
378,012 |
Current assets |
109,699
|
89,600
|
213,923 |
Current liabilities |
282,370
|
241,479
|
322,485 |
Equity capital |
38,969
|
40,174
|
49,930 |
- share capital |
101
|
95
|
98 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
12.0%
|
14.1%
|
13.2% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.5%
|
16.1%
|
27.9% |
Return on assets (ROA) |
23.9%
|
18.3%
|
18.4% |
Current ratio |
38.8%
|
37.1%
|
66.3% |
Return on equity (ROE) |
115.5%
|
87.6%
|
97.9% |
Change turnover |
99,879
|
48,236
|
38,343 |
Change turnover % |
43%
|
28%
![]() |
28% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.